Trial · NCT02656017
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in the Gastrointestinal Symptoms Rating Scale (GSRS) to 24 Months | Baseline, 2 weeks, 6 weeks, 1 month, 3 months and every 3 months thereafter to 24 months | score on a scale | MEAN | |
| PRIMARY | Drug Tolerability | Baseline, 2 weeks, 6 weeks, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Rate of Serious Adverse Events (SAE) | 26 months | Participants who received and took metformin or placebo | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Quality of Life Physical Component | Baseline, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | score on a scale | MEAN |
| SECONDARY | Quality of Life Mental Component | Baseline, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | score on a scale | MEAN |
| SECONDARY | Back Pain Frequency Over the Past 3 Months Since Last Visit | Baseline, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | odds ratio | NUMBER |
| SECONDARY | Estimated Glomerular Filtration Rate (eGFR) | Baseline, 2 weeks, and 6 weeks, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | ml/min/1.73m^2 | MEAN |
| SECONDARY | Total Kidney Volume From Magnetic Resonance Imaging | Baseline, 6 months, 12 months, 18 months, 24 months | Intention to treat analysis | annual percent change | MEAN |
| SECONDARY | Total Kidney Cyst Volume From Magnetic Resonance Imaging | Baseline, 6 months, 12 months, 18 months, 24 months | Intention to treat analysis | annual percent change | MEAN |
| SECONDARY | Liver Volume From Magnetic Resonance Imaging | Baseline, 6 months, 12 months, 18 months, 24 months | Intention to treat analysis | annual percent change | MEAN |
| SECONDARY | Liver Cyst Volume From Magnetic Resonance Imaging | Baseline, 6 months, 12 months, 18 months, 24 months | Intention to treat analysis | annual percent change | MEAN |
| SECONDARY | Frequency Abdominal Fullness Interfered With Ability to Perform Usual Physical Activity Over the Past 3 Months Since Last Visit. | Baseline, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | odds ratio | NUMBER |
| SECONDARY | Interference of Pain With Sleep Over the Past 3 Months Since Last Visit | Baseline, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | odds ratio | NUMBER |
| SECONDARY | Interference of Pain With Strenuous Physical Activity Over the Past 3 Months Since Last Visit | Baseline, 1 month, 3 months and every 3 months thereafter to 24 months | Intention to treat analysis | odds ratio | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02656017/outcomes